Therefore, the objectives of our study were to explore the effect of TET1 in chemotherapy outcomes of CCA patients and to investigate the possible correlations between TET1 and P‐gp in CCA with gemcitabine resistance. The gene discussed is TET1; the disease is cholangiocarcinoma.